Tenon Medical (TNON) Stock Price

Tenon Medical Price

NYSE·CLOSED
3.73
​
Market closed

Over the last 6 years Tenon Medical grew revenue by 104.7% annually, reaching 3.94 M USD. For Tenon Medical, the net margin of -318.4% is up versus -4,405.0% a few years ago. The consensus 12-month price target for Tenon Medical is 2.81 USD, about 24.8% below where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

Tenon Medical stock price

Access this data via the Eulerpool API

Tenon Medical business model & stock analysis

Tenon Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Los Gatos, California and currently employs 22 full-time employees. The company went IPO on 2022-04-27. Tenon Medical, Inc. is a medical device company. The firm has developed an inferior-posterior approach to the sacroiliac joint using a single, robust, titanium implant for the treatment of the most common types of sacroiliac joint (SI Joint) disorders that cause lower back pain. The Catamaran SI Joint Fusion System (The Catamaran System) is designed to transfix and stabilize the SI Joint. The System features the Catamaran Fixation Device, which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach are also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Company’s subsidiary is Tenon Technology AG.

Frequently asked questions about Tenon Medical

Analysts currently set an average price target of 2.81 USD for the Tenon Medical stock (median: 2.81 USD), implying -24.8 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the Tenon Medical stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Tenon Medical to generate revenue of 5.79 M USD and earnings per share of -92.68 USD.

Converted at the current exchange rate, the Tenon Medical share trades at 3.33 EUR (3.73 USD).

The expected revenue of Tenon Medical is 5.79 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Tenon Medical is -28.74 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Tenon Medical is currently -0.04. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Tenon Medical stock.

The price-to-sales ratio (P/S) of Tenon Medical is currently 0.20. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Tenon Medical stock.

The Eulerpool Quality Score for Tenon Medical is 3/10.

The ISIN of Tenon Medical is US88066N3035. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Tenon Medical is TNON. The ticker symbol is used to trade Tenon Medical shares on the stock exchange.

Fair ValueTerminal
3.54 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
179,272.73 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website tenonmed.com
Currency
USD
Initial public offering
Apr 27, 2022
ISIN
US88066N3035
Cusip
88066N204
Market capitalization
5.04 M USDMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2026
-0.04
P/Ee 2027
-0.07
P/Ee 2028
-2.40
P/Ee 2029
-8.38
P/Ee 2030
24.38
P/S
P/Se
0.20
EV/EBIT
—
P/B Ratio
1.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-242.35 %
Gross Margin
59.79 %
EBIT Margin
-324.34 %
Net Margin
-318.36 %
EPS (Earnings Per Share)
-40.49 USD
Net Debt / EBIT
0.28
Debt/Equity
0.03
Last updated Oct 6, 2026, 8:10 AM

Tenon Medical Peer Group

All fundamentals and in-depth analysis of Tenon Medical

Our stock analysis for Tenon Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tenon Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.